2023-03-31-accounts - United Kingdom And Ireland Oesophagogastric Cancer Group

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Trustees’ Annual Report for the period

From 24/03/2022 To 31/03/2023

Charity name: United Kingdom and Ireland Oesophagogastric Cancer Group

Charity registration number: 1198358

Objectives and Activities

	SORP reference
Summary of the purposes of the charity as set out in its governing document	Para 1.17	For the public benefit, the advancement of health and saving of lives by (but not limited to) the following means: a) providing a forum to share knowledge and for discussion about medical cases in the field of oncology; b) providing information and advice to those who work in the field of oncology about care and treatment of cancers, including but not limited to oesophageal and gastric cancer; and c) carrying out such other charitable activities as the trustees see fit from time to time which would improve the standard of care and treatment of oesophageal and gastric cancer patients and cancerpatientsgenerally.
Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts.	Para 1.17 and 1.19	• Provides education/advocacy/advice/information • Workshops, conferences, seminars and/or lectures • professional training
Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit	Para 1.18	THE UKIOG Charity aims to improve outcomes for Oesophago gastric cancer patients by sharing of best practice, supporting research and facilitating training. All of these activities are aimed at ultimately improving the care of cancer patients and therefore are a benefit to the public.

Additional information (optional) You may choose to include further statements where relevant about:

SORP reference UKIOG does not presently make grants. Para 1.38 Policy on grant making

Policy on social investment including program related investment	Para 1.38	UKIOG does not carry out social investments.
Contribution made by volunteers	Para 1.38	The founders, steering group and committees are formed of volunteers who provide their time free of charge. The only payments made are to faculty / speakers to support their attendance at the face to face meetings.
Other

Achievements and Performance

	SORP reference
Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole.	Para 1.20	The charity has successfully run 4 virtual National MDTs where complex cancer cases are discussed and then learnings from these cases disseminated. This has harmonised best practice and highlighted where centres are offering procedures or other treatments not on offer in other centres. This has directly led to the transfer of patients care to super specialist centres. We also ran our first face to face meeting attended by 130 people from across all the healthcare professions who look after Oesophageal and gastric cancer patients. This meeting highlighted the latest areas of research and shared best practice in managing these complex patients. Feedback from this meeting was extremely positive with 95% of people stating they would attend again. Lastly, we formed the Research committee which took over from the NCRI Oesophago Gastric subgroup after the NCRI shut down. This group provides a mechanism for researchers to discuss their proposed projects, get feedback and then receive letters of support from UKIOG to go with the application. It also supports ongoing research projects with recruitment and helps determine what the research priorities should be for Oesophago-Gastric cancer over the next 5 years based on feedback from both patients and clinicians.

Additional information (optional) You may choose to include further statements	Additional information (optional) You may choose to include further statements	where relevant about:
Achievements against objectives set	Para 1.41	We achieved our goals for this period.
Performance of fundraising activities against objectives set	Para 1.41	We fund our activities via sponsorship from medical companies. This pays for the events and the remaining money is then available for other activities.
Investment performance against objectives	Para 1.41	N/A
Other

Financial Review

Financial Review
Review of the charity’s financial position at the end of the period	Para 1.21	We ended the financial period with a sum of £31,071. We have no other assets and no liabilities.
Statement explaining the policy for holding reserves stating why they are held	Para 1.22	We don’t aim to keep a reserve, but the sum left at the end of this financial year is to allow us to prepare for the subsequent years activities, cover secretarial support and to invest in a professional website to allow us to disseminate the training materials we have created.
Amount of reserves held	Para 1.22	N/A
Reasons for holding zero reserves	Para 1.22	N/A
Details of fund materially in deficit	Para 1.24	N/A
Explanation of any uncertainties about the charity continuing as a going concern	Para 1.23	N/A

Additional information (optional) You may choose to include further statements	Additional information (optional) You may choose to include further statements	where relevant about:
The charity’s principal sources of funds (including any fundraising)	Para 1.47	Sponsorship from medical companies.
Investment policy and objectives including any social investment policy adopted	Para 1.46	N/A
A description of the principal risks facing the charity	Para 1.46	None at present. After the first sponsored events the sponsors have made it clear they are very happy to continue sponsoring more events.
Other

Structure, Governance and Management

Description of charity’s trusts:		N/A
Type of governing document (trust deed, royal charter)	Para 1.25	CIO Constitution.
How is the charity constituted? (e.g unincorporated association, CIO)	Para 1.25	CIO
Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees	Para 1.25	The current three trustees were responsible for the creation of UKIOG and its formation as a charity. New trustees will be appointed as required by a process of self nomination and then voting by the steering committee and all the sub committees that form UKIOG

Additional information (optional) You may choose to include further statements where relevant about:

Policies and procedures adopted for the induction and training of trustees	Para 1.51	We will use the Charity Excellence Framework courses to trainee new trustees.
The charity’s organisational structure and any wider network with which the charity works	Para 1.51	The charity is formed of the three trustees, a steering committee and then a Research Committee. Additional committees will be set up of the course of 2024.
Relationship with any related parties	Para 1.51	None
Other

Reference and Administrative details

Charity name	United Kingdom and Ireland Oesophagogastric Cancer Group
Other name the charity uses
Registered charitynumber	1198358
Charity’s principal address	Velindre Cancer Centre, Velindre Road, Whitchurch, Cardiff, CF14 2TL

Names of the charity trustees who manage the charity

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20	Trustee name	Office (if any)	Dates acted if not for whole year	Name of person (or body) entitled to appoint trustee (ifany)
	Thomas Crosby
	Christopher Peters
	Elizabeth Smyth

– Corporate trustees names of the directors at the date the report was approved

Director name N/A

Name of trustees holding title to property belonging to the charity

Trustee name	Dates acted if not for whole year
None

Funds held as custodian trustees on behalf of others

Description of the assets None held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets

Additional information (optional)

Names and addresses of advisers (Optional information)

Names and addresses of advisers (Optional information)	Names and addresses of advisers (Optional information)	Names and addresses of advisers (Optional information)
Type of adviser Name Address




Name of chief executive or names of senior staff members (Optional information)

Exemptions from disclosure

Reason for non-disclosure of key personnel details

N/A

Other optional information

N/A

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Full name(s) Position (eg Secretary, Chair, etc) Date
	Christopher John Peters
	Trustee
	11/9/2024
	11/9/2024

Date	Description	Income MoneyIN	Expense MoneyOUT
03/01/2023	Payment from Lloyds bank due to complaint	£40
09/01/2023	BVM Sponsorshipof Annual Meeting2023	£2,000
03/02/2023	Expensepaid to facultyof annual meeting- Dr Vignseswaran		£89.89
03/02/2023	Expensepaid to facultyof annual meeting- Thea Towell		£388.45
06/02/2023	Expensepaid to facultyof annual meeting- Massimiliano Di Pietro		£41.80
07/02/2023	BMS Sponsorshipof Annual Meeting2023	£10,000
10/02/2023	Aquilant Sponsorshipof Annual Meeting2023	£2,500
16/02/2023	Expensepaid to facultyof annual meeting- Tom Crosby		£118
17/02/2023	Servier Sponsorshipof Annual Meeting2023	£10,000
20/02/2023	Bank Service Charges		£7
28/02/2023	Payment to Royal Societyof Medicine for Event - Annual Meeting		£17,822.42
08/03/2023	Amgen Sponsorshipof Annual Meeting2023	£10,000
08/03/2023	Payment for website		£1.20
17/03/2023	Merck Sponsorshipof Annual Meeting2023	£10,000
17/03/2023	Astellas Sponsorshipof Annual Meeting2023	£5,000

	Total Current Assets	0
	Total Current Liabilities	0

Overall Balance £40 £2,400 £1,950.11 £1,561.66 £1,519.86 £11,519.86 £14,019.86 £13,901.86 £23,901.86 £23,894.86 £6,072.44 £16,072.44 £16,071.24 £26,071.24 £31,071.24

Independent examiner's report on the accounts

Section A Independent Examiner’s Report

Report to the trustees Charity Name United Kingdom and Ireland Oesophagogastric Cancer Group On accounts for the year 2023 Charity no 1198358 ended (if any) Set out on pages

(remember to include the page numbers of additional sheets)

I report to the trustees on my examination of the accounts of the above charity (“the Trust”) for the year ended 31/03/2023. Responsibilities and As the charity's trustees, you are responsible for the preparation of the basis of report accounts in accordance with the requirements of the Charities Act 2011 (“the Act”).

I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent examiner's statement I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination (other than that disclosed below *) which gives me cause to believe that in, any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Please delete the words in the brackets if they do not apply.

Signed: Date: 16/09/2024 Name: Dr Murray A J Hudson Relevant professional Qualification: MBChB (University of Edinburgh 2009) qualification(s) or body Registered as a Medical Practitioner with the General Medical Council – (if any): GMC# 7041191 Address: 45 Pottery Lane London W11 4LY

Section B Disclosure

Only complete if the examiner needs to highlight material matters of concern (see CC32, Independent examination of charity accounts: directions and guidance for examiners).

Oct 2018

IER

Give here brief details of any items that the examiner wishes to disclose .

Oct 2018

IER